Brief: Gracell Biotechnologies Reports Second Quarter 2021 Unaudited Financial Results
17/08/2021 12:09
Aug 17 (Reuters) - Gracell Biotechnologies Inc GRCL.O :
* GRACELL BIOTECHNOLOGIES REPORTS SECOND QUARTER 2021
UNAUDITED
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* GRACELL BIOTECHNOLOGIES INC QTRLY LOSS PER SHARE $0.04
* GRACELL BIOTECHNOLOGIES INC - AS OF JUNE 30, 2021, HAD
$318.1
MILLION IN CASH AND CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
Source text for Eikon: ID:nGNX2Xqnnl
Further company coverage: GRCL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gracell Biotechnologies
See all newsBrief: Gracell Biotechnologies Announces Shareholders’ Approval Of Merger Agreement
Brief: Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
Newscasts - UK Day Ahead: European shares start last week of 2023 on strong footing
Live Markets: European futures rise after holiday break
Press Digest: British Business - Dec 27